@article{eecb17dc923f400f86b5f5a6b3547ede,
title = "Controversies in Stroke: Should Patients With Embolic Stroke of Undetermined Source Undergo Intensive Heart Rhythm Monitoring With an Implantable Loop Recorder?",
keywords = "anticoagulation, atrial fibrillation, electrocardiography, ambulatory, embolic stroke, ischemic stroke, risk factors",
author = "Kim, {Anthony S.} and Hooman Kamel and Bernstein, {Richard A.} and Monika Manchanda and Caprio, {Fan Z.}",
note = "Funding Information: Dr Kim reports grant support from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS), National Center for Advancing Translational Sciences (NCATS)‚ NIH/National Institute on Minority Health and Health Disparities (NIMHD)‚ Patient-Centered Outcomes Research Institute (PCORI)‚ and American Heart Association/American Stroke Association (AHA/ASA) and is Associate Editor for NEJM Journal Watch: Neurology. Dr Kamel serves as a principal investigator for the NIH-funded ARCADIA trial (Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke; NINDS U01NS095869), which receives in-kind study drug from the Bristol-Myers Squibb-Pfizer Alliance for Eliquis and ancillary study support from Roche Diagnostics; as Deputy Editor for JAMA Neurology; on clinical trial steering/executive committees for Medtronic, Janssen, and Javelin Medical; and on end point adjudication committees for NovoNordisk and Boehringer-Ingelheim. Dr Bernstein reports consulting and speakers relationships with Boehringer-Ingelheim, Pfizer, Amgen, AbbVie, Abbott, Bristol Myers, AstraZeneca, and Medtronic. The other authors report no conflicts.",
year = "2022",
month = oct,
day = "1",
doi = "10.1161/STROKEAHA.122.037342",
language = "English (US)",
volume = "53",
pages = "3243--3247",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "10",
}